Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial
- PMID: 26112885
- PMCID: PMC4589656
- DOI: 10.1093/eurheartj/ehv292
Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial
Abstract
Aims: This trial was designed to test the hypothesis that shock efficacy during follow-up is not impaired in patients implanted without defibrillation (DF) testing during first implantable cardioverter-defibrillator (ICD) implantation.
Methods and results: Between February 2011 and July 2013, 1077 patients were randomly assigned (1 : 1) to first time ICD implantation with (n = 540) or without (n = 537) DF testing. The intra-operative DF testing was standardized across all participating centres, and all ICD shocks were programmed to 40 J irrespective of DF test results. The primary end point was the average first shock efficacy (FSE) for all true ventricular tachycardia and fibrillation (VT/VF) episodes during follow-up. The secondary end points included procedural data, serious adverse events, and mortality. During a median follow-up of 22.8 months, the model-based FSE was found to be non-inferior in patients with an ICD implanted without a DF test, with a difference in FSE of 3.0% in favour of the no DF test [confidence interval (CI) -3.0 to 9.0%, Pnon-inferiority <0.001 for the pre-defined non-inferiority margin of -10%). A total of 112 procedure-related serious adverse events occurred within 30 days in 94 patients (17.6%) tested compared with 89 events in 74 patients (13.9%) not tested (P = 0.095).
Conclusion: Defibrillation efficacy during follow-up is not inferior in patients with a 40 J ICD implanted without DF testing. Defibrillation testing during first time ICD implantation should no longer be recommended for routine left-sided ICD implantation.
Keywords: Defibrillation testing; Implantable cardioverter-defibrillator.
© The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology.
Figures


Comment in
-
Device therapy: Defibrillation testing unnecessary during routine cardioverter-defibrillator implantation.Nat Rev Cardiol. 2015 Sep;12(9):501. doi: 10.1038/nrcardio.2015.111. Epub 2015 Jul 14. Nat Rev Cardiol. 2015. PMID: 26169792 No abstract available.
-
Defibrillation testing is not required during routine ICD implantation.Eur Heart J. 2015 Oct 1;36(37):2508-9. doi: 10.1093/eurheartj/ehv324. Epub 2015 Jul 22. Eur Heart J. 2015. PMID: 26201511 No abstract available.
References
-
- Russo AM, Chung MK. Is defribrillation testing necessary? Cardiol Clin 2014;32:211–224. - PubMed
-
- Pires LA, Johnson KM. Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough? J Cardiovasc Electrophysiol 2006;17:140–145. - PubMed
-
- Christ G, Becker R, Voss F, Kelemen K, Senges-Becker J, Hauck M, Schoels W, Bald I, Katus H, Bauer A. Indications for predismissal testing with arrhythmia-induction in patients receiving an implatable cardioverter defibrillator. Clin Res Cardiol 2007;96:613–620. - PubMed
-
- Brignole M, Raciti G, Bongiorni MG, De Martino G, Favale S, Gasparini M, Luise R, Occhetta E, Proclemer A. Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice: a nation-wide survey. Europace 2007;9:540–543. - PubMed
-
- Healey JS, Dorian P, Mitchell LB, Talajic M, Philippon F, Simpson C, Yee R, Morillo CA, Lamy A, Basta M, Birnie DH, Wang X, Nair GM, Crystal E, Kerr CR, Connolly SJ, CREDIT Investigators. Canadian Registry of ICD Implant Testing procedures (CREDIT): current practice, risks, and costs of intraoperative defibrillation testing. J Cardiovasc Electrophysiol 2010;21:177–182. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous